Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher Scientific (TMO)
:TMO
TMO Analyst Ratings
Strong Buy
15 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TMO Stock 12 Month Forecast
Average Price Target
$662.00
▲(27.33% Upside)
| Highest Price Target$715.00 | Average Price Target$662.00 | Lowest Price Target$570.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citi
Reiterated
03/04/25
Stifel Nicolaus
Reiterated
02/26/25
Jefferies
Reiterated
02/25/25
Goldman Sachs
Reiterated
02/25/25
Bank of America Securities
Reiterated
02/25/25
Barclays
Reiterated
02/25/25
Leerink Partners
Reiterated
02/25/25
Wells Fargo
Reiterated
02/10/25
CMB International Securities
Reiterated
02/07/25
Scotiabank
Reiterated
02/03/25
Raymond James
$650→$667
Buy
28.29%
Upside
Reiterated
02/03/25
Raymond James Sticks to Its Buy Rating for Thermo Fisher (TMO)We reiterate our Outperform rating on shares of Thermo Fisher following a solid close in 4Q24, which showed stronger revenues, in-line margins, and better adjusted EPS.
Robert W. Baird
$632→$660
Buy
26.95%
Upside
Reiterated
01/31/25
Thermo Fisher price target raised to $660 from $632 at BairdThermo Fisher price target raised to $660 from $632 at Baird
TD Cowen
$686
Buy
31.95%
Upside
Assigned
01/31/25
Thermo Fisher's Promising Outlook and Strategic Management Drive Analyst's Positive Rating
Bernstein
$630→$690
Buy
32.72%
Upside
Reiterated
01/31/25
Thermo Fisher's Strong Q4 Performance and Strategic Guidance Justify Outperform Rating and Target Price IncreaseWe believe that 3-4% organic growth with 90bps of margin expansion is a reasonable guide for FY25, with some potential upside. When we upgraded the beginning of the month we said there was some risk around their 2025 guide, as the company had to strike a very careful balance: On the one hand, investors had to believe that Thermo was setting a low bar, as the stock “works’ when it can beat and raise throughout the year. On the other hand, the company couldn’t be too cautious in its guide and risk kicking off a new round of existential questions about the sector (which, to some extent, Danaher - not covered - did on Wednesday before dropping 10%). We believe they were able to thread that needle perfectly, and we think the stock reaction of +7% was warranted.
Morgan Stanley
$647→$678
Buy
30.41%
Upside
Reiterated
01/31/25
Analysts' Top Healthcare Picks: Thermo Fisher (TMO), Vir Biotechnology (VIR)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
Reiterated
03/04/25
Stifel Nicolaus
Reiterated
02/26/25
Jefferies
Reiterated
02/25/25
Goldman Sachs
Reiterated
02/25/25
Bank of America Securities
Reiterated
02/25/25
Barclays
Reiterated
02/25/25
Leerink Partners
Reiterated
02/25/25
Wells Fargo
Reiterated
02/10/25
CMB International Securities
Reiterated
02/07/25
Scotiabank
Reiterated
02/03/25
Raymond James
$650→$667
Buy
28.29%
Upside
Reiterated
02/03/25
Raymond James Sticks to Its Buy Rating for Thermo Fisher (TMO)We reiterate our Outperform rating on shares of Thermo Fisher following a solid close in 4Q24, which showed stronger revenues, in-line margins, and better adjusted EPS.
Robert W. Baird
$632→$660
Buy
26.95%
Upside
Reiterated
01/31/25
Thermo Fisher price target raised to $660 from $632 at BairdThermo Fisher price target raised to $660 from $632 at Baird
TD Cowen
$686
Buy
31.95%
Upside
Assigned
01/31/25
Thermo Fisher's Promising Outlook and Strategic Management Drive Analyst's Positive Rating
Bernstein
$630→$690
Buy
32.72%
Upside
Reiterated
01/31/25
Thermo Fisher's Strong Q4 Performance and Strategic Guidance Justify Outperform Rating and Target Price IncreaseWe believe that 3-4% organic growth with 90bps of margin expansion is a reasonable guide for FY25, with some potential upside. When we upgraded the beginning of the month we said there was some risk around their 2025 guide, as the company had to strike a very careful balance: On the one hand, investors had to believe that Thermo was setting a low bar, as the stock “works’ when it can beat and raise throughout the year. On the other hand, the company couldn’t be too cautious in its guide and risk kicking off a new round of existential questions about the sector (which, to some extent, Danaher - not covered - did on Wednesday before dropping 10%). We believe they were able to thread that needle perfectly, and we think the stock reaction of +7% was warranted.
Morgan Stanley
$647→$678
Buy
30.41%
Upside
Reiterated
01/31/25
Analysts' Top Healthcare Picks: Thermo Fisher (TMO), Vir Biotechnology (VIR)
Best Analysts Covering Thermo Fisher
Which Analyst Should I Follow If I Want to Buy TMO and Sell After:
1 Month
xxx
Success Rate
11/19 ratings generated profit
Average Return
+0.52%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.89% of your transactions generating a profit, with an average return of +0.52% per trade.
3 Months
xxx
Success Rate
29/41 ratings generated profit
Average Return
+4.34%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.73% of your transactions generating a profit, with an average return of +4.34% per trade.
1 Year
Success Rate
26/41 ratings generated profit
Average Return
+13.77%
reiterated a buy rating 2 months ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 63.41% of your transactions generating a profit, with an average return of +13.77% per trade.
2 Years
xxx
Success Rate
28/41 ratings generated profit
Average Return
+27.28%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 68.29% of your transactions generating a profit, with an average return of +27.28% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TMO Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
31
18
22
29
26
Hold
4
4
4
6
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
22
26
35
32
Each month's total comprises the sum of three months' worth of ratings.
TMO Financial Forecast
TMO Stock Forecast FAQ
What is TMO’s average 12-month price target, according to analysts?
Based on analyst ratings, Thermo Fisher Scientific’s 12-month average price target is $662.00.
What is TMO’s upside potential, based on the analysts’ average price target?
Thermo Fisher Scientific has 27.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TMO a Buy, Sell or Hold?
Thermo Fisher Scientific has a consensus rating of Strong Buy which is based on 15 buy ratings, 3 hold ratings and 0 sell ratings.
What is Thermo Fisher Scientific’s price target?
The average price target for Thermo Fisher Scientific is $662.00. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $715.00 ,the lowest forecast is $570.00. The average price target represents 27.33% Increase from the current price of $519.9.
The highest analyst price target is $715.00 ,the lowest forecast is $570.00. The average price target represents 27.33% Increase from the current price of $519.9.
What do analysts say about Thermo Fisher Scientific?
Thermo Fisher Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of TMO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.